Search

everythinglearnresearchcommunity

for

Search:↓

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Non-invasive methods can effectively diagnose and manage alopecia areata.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Upadacitinib improved multiple immune-related conditions in one patient.

Stressful life events may trigger alopecia areata.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Scalp skin barrier affects hair loss; personalized treatments needed.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Apremilast did not work for treating severe alopecia areata.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Current treatments for severe alopecia areata are unsatisfactory, highlighting the need for better options.

Red laser therapy helped regrow hair in an alopecia areata patient within 21 days.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

People with alopecia areata have higher insulin resistance.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

A machine learning model can predict alopecia areata early using specific gene markers.

Distinct miRNA signatures could help diagnose and treat severe Alopecia Areata.